MongoDB’s shares surged by 16% in extended trading following the release of its fiscal second-quarter earnings report. The company exceeded LSEG consensus expectations with an adjusted earnings per share of 70 cents, compared to the expected 49 cents. Additionally, MongoDB reported revenue of $478.1 million, surpassing the anticipated $464.1 million. In the quarter ending on
0 Comments
As the tech earnings parade continues, Marvell Technology stands out with an impressive 8% increase after-hours following a better-than-expected revenue report for the latest quarter. Despite this positive performance, Marvell is still down 18% from its March high. Nonetheless, shares have shown an 8% increase in the past month, indicating potential for growth in the
0 Comments
Employers have increasingly adopted automated retirement savings programs, such as auto-enrollment and auto-escalation, to encourage workers to save more for their future. These policies were initially believed to have a significant positive impact on employees’ retirement savings. However, new research suggests that the actual benefits may not be as substantial as previously thought. Factors like
0 Comments
The landscape of cannabis consumption has undergone a significant transformation in New York City, particularly along the prestigious Fifth Avenue. While traditionally known for upscale retail stores like Cartier and Saks, this iconic stretch now boasts a new addition – a recreational marijuana dispensary. The legalization of adult-use marijuana in New York state has paved
0 Comments
In an industry that has already been struggling with profitability, cash-strapped low-cost and deep discounter airlines are now faced with a new challenge. The impact of engine repairs, combined with a significant decrease in revenue due to an oversupply of flights, has forced airlines like Spirit Airlines, JetBlue Airways, and Frontier Airlines to reevaluate their
0 Comments
The Food and Drug Administration has recently authorized Novavax’s updated protein-based Covid vaccine for emergency use in individuals 12 years old and older. This development opens the door for Novavax’s vaccine to compete with Pfizer and Moderna’s vaccines during the upcoming fall and winter seasons. Targeting Omicron Subvariant JN.1 Novavax’s vaccine is designed to target
0 Comments
In today’s real estate market, buying a home has become less affordable for many individuals. The median sales price for homes has continued to rise, reaching $422,600 in July – an increase of 4.2% from the previous year. This surge in home prices has created a financial strain on potential buyers, making it difficult for
0 Comments